The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.103%)
Open: 1,942.00
High: 1,958.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sector movers: Shire soars as M&A fever boosts pharma, health stocks

Fri, 20th Jun 2014 13:56

News that Shire has rejected a £27bn approach by AbbVie sent shares in the pharmaceutical and healthcare equipment sectors higher on Friday as yet more M&A continued to give sentiment a boost."A bit of M&A excitement has been just the ticket to enliven trading on what may otherwise have been something of a lacklustre end to the week," said David Madden, Market Analyst at IG.Shire's shares were up nearly 16% at 4,332p in afternoon trade after the company said it has received and rejected a 4,626p proposal from Chicago-based AbbVie, a spin-off from Abbott Laboratories.Shire said the approach "fundamentally undervalued" the company and its prospects, assuring investors that it has a "strong independent future". Analysts at Panmure Gordon said that they weren't surprised by the rejection with the price AbbVie being "barely adequate". The broker said that Shire's rare diseases business is one of the "hottest assets in biopharmaceuticals".The proposal was the latest in a wave of M&A activity to hit the global pharma/healthcare industry, showing that large multinational corporations are ready and willing to use their treasure chests to finance new deals. Recent bid talks, such as Pfizer's failed near-£70bn takeover of AstraZeneca, have also brought to light the issue of 'tax inversion' with foreign companies looking to redomicile abroad for tax purposes, raising the possibility of increased interest in UK companies.Chief Market Analyst Michael Hewson from CMC Markets UK said: "With corporate tax rates in the UK lower than in the US, and likely to get lower, and high penalties for US companies repatriating cash, management in these companies have been looking at relocating their tax domiciles as means to save money, as well as become more profitable."Shire admitted that this was one of the 'sticking points' in the AbbVie proposal, raising "concerns regarding the execution risks associated with the proposed inversion structure".Smith & Nephew, the medical devices maker which itself has been the centre of bid speculation in recent months, was up 2% today. BTG, GlaxoSmithKline, AstraZeneca, Synergy Health, Vectura, Hikma and Dechra were also rising strongly.Top performing sectors so far todayIndustrial Metals & Mining 1,133.80 +2.46%Pharmaceuticals & Biotechnology 13,254.99 +2.26%Health Care Equipment & Services 6,023.70 +2.01%Automobiles & Parts 8,699.94 +1.22%Technology Hardware & Equipment 1,083.86 +0.90%Bottom performing sectors so far todayMobile Telecommunications 4,370.82 -0.93%Real Estate Investment Trusts 2,695.26 -0.68%Real Estate Investment & Services 2,615.52 -0.58%Food & Drug Retailers 3,725.20 -0.55%Fixed Line Telecommunications 4,475.55 -0.52%BC
More News
20 Apr 2022 09:16

IN BRIEF: Hikma gets preliminary US approval for Custopharm acquisition

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Receives preliminary approval from the US Federal Trade Commission for its planned acquisition of Custopharm Inc. Back in September, Hikma agreed to buy the California, US-based generic injectable products company for a total of up to USD425 million.

Read more
20 Apr 2022 07:39

Hikma gets preliminary approval from US FTC for Custopharm deal

(Sharecast News) - Hikma Pharmaceuticals has received preliminary approval from the US Federal Trade Commission for the acquisition of sterile injectables company Custopharm Inc from Water Street Healthcare for up to $425m.

Read more
12 Apr 2022 10:11

LONDON BROKER RATINGS: JPMorgan lowers Rolls-Royce; UBS likes Ryanair

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
10 Mar 2022 16:10

UK dividends calendar - next 7 days

Friday 11 March  
Avon Protection PLCdividend payment date
Civitas Social Housing PLCdividend payment date
Impact Healthcare REIT PLCdividend payment date
Virgin Money UK PLCdividend payment date
Monday 14 March  
Tritax EuroBox PLCdividend payment date
Tuesday 15 March 
Hipgnosis Songs Fund Ltddividend payment date
Invesco Perpetual UK Smaller Cos Investment Trust PLCdividend payment date
Merchants Trust PLCdividend payment date
Wednesday 16 March  
no events scheduled 
Thursday 17 March  
Anglo American PLCex-dividend date
Anglo American PLCspecial ex-dividend date
Bellevue Healthcare Trust PLCex-dividend date
Blackrock Income & Growth Investment Trust PLCdividend payment date
BlacKRock World Mining Trust PLCex-dividend date
Brooks Macdonald Group PLCex-dividend date
Crest Nicholson Holdings PLCex-dividend date
Dunelm Group PLCex-dividend date
FW Thorpe PLCex-dividend date
FW Thorpe PLCspecial ex-dividend date
Gore Street Energy Storage Fund PLCex-dividend date
HgCapital Trust PLCex-dividend date
Hikma Pharmaceuticals PLCex-dividend date
Ideagen PLCdividend payment date
JPMorgan Mid Cap Investment Trust PLCex-dividend date
Knights Group Holdings PLCdividend payment date
M&G PLCex-dividend date
Murray Income Trust PLCdividend payment date
NatWest Group PLCex-dividend date
RM PLCex-dividend date
Segro PLCex-dividend date
Spirent Communications PLCex-dividend date
Standard Life Private Equity Trust PLCex-dividend date
Treatt PLCdividend payment date
Trifast PLCex-dividend date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
3 Mar 2022 10:02

LONDON BROKER RATINGS: Downgrades for Hikma Pharma and Royal Mail

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
3 Mar 2022 08:28

LONDON BRIEFING: LSEG says Refinitiv savings bigger, ahead of schedule

(Alliance News) - London Stock Exchange Group on Thursday said 2021 was a successful year following the acquisition of Refinitiv, leaving the stock exchange operator well positioned as a financial market infrastructure and data business.

Read more
2 Mar 2022 09:52

LONDON BROKER RATINGS: Downgrades for AB Foods, BT and Royal Mail

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 Feb 2022 09:40

IN BRIEF: Hikma Pharmaceuticals launches first phase of share buyback

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Instructs Citigroup Global Markets Ltd, part of Citigroup Inc, to conduct the USD150 million first tranche of the USD300 million share buyback that it announced on Thursday. The initial phase will begin on Friday and end by June 25. Hikma had announced the buyback programme with its annual results, saying it reflected its strong cash generation, balance sheet strength, and confidence in future growth prospects. Hikma also had declared a final dividend of 36 cents, a 5.9% boost from a shareholder payout of 34 cents the year before. Its full-year dividend amounted to 54 US cents, up 8.0% from 50 cents.

Read more
25 Feb 2022 08:22

LONDON BRIEFING: IAG expects to fly 85% of pre-virus capacity in 2022

(Alliance News) - International Consolidated Airlines Group on Friday posted a narrowed loss for 2021, saying that after the setback caused by Omicron at the end of the year, bookings have rebounded strongly and it expects to fly 85% of its 2019 capacity in 2022.

Read more
24 Feb 2022 10:31

TOP NEWS: Hikma Pharmaceutical records revenue growth and lifts payout

(Alliance News) - Hikma Pharmaceutical PLC on Thursday reported full-year revenue growth on a "strong" performance by its three business segments and lifted its shareholder payout.

Read more
24 Feb 2022 07:58

Hikma Pharmaceutical delivers year of 'solid growth' and 'strategic momentum'

(Sharecast News) - Drugmaker Hikma Pharmaceutical said on Thursday that it had delivered another successful year of "solid growth and continued strategic momentum", with both revenue and operating profits improving year-on-year.

Read more
24 Feb 2022 07:50

LONDON MARKET PRE-OPEN: Share buybacks for Lloyds Banking and Hikma

(Alliance News) - Stock prices in London are seen opening sharply lower, with the FTSE 100 called down almost 200 points, amid fear of a full-scale war in eastern Europe after Russia announced the beginning of a military operation in Ukraine.

Read more
17 Feb 2022 16:08

UK earnings, trading statements calendar - next 7 days

Friday 18 February  
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 21 February 
Bank of Cyprus Holdings PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Tristel PLCTrading Statement
Wilmington PLCHalf Year Results
Tuesday 22 February 
Antofagasta PLCFull Year Results
Bank of Georgia Group PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Blancco Technology Group PLCHalf Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Coca-Cola HBC AGFull Year Results
Hargreaves Lansdown PLCHalf Year Results
HSBC Holdings PLCFull Year Results (at 0400 GMT)
InterContinental Hotels Group PLCFull Year Results
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Synectics PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wednesday 23 February 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Barclays PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
CAP-XX LtdHalf Year Results
Georgia Capital PLCFull Year Results
International Personal Finance PLCFull Year Results
Irish Residential Properties REIT PLCFull Year Results
Metro Bank PLCFull Year Results
Hochschild Mining PLCFull Year Results
Photo-Me International PLCFull Year Results
Rio Tinto PLCFull Year Results
Seraphim Space Investment Trust PLCHalf Year Results
Ted Baker PLCTrading Statement
Unite Group PLCFull Year Results
Thursday 24 February 
Anglo American PLCFull Year Results
BAE Systems PLCFull Year Results
Centrica PLCFull Year Results
Conduit Holdings LtdFull Year Results
Derwent London PLCFull Year Results
Drax Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Inchcape PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Rathbone Group PLCFull Year Results
Ricardo PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
St James's Place PLCFull Year Results
Tremor International LtdFull Year Results
WPP PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.